Inventor · disambiguated record
Duong Tran
Also filed as: TRAN DUONG · TRAN DUONG D · TRAN DUONG DUC-PHI
20 granted patents·2 pending applications·107 citations·filing 2010–2024
95Inventor score
Files withGILEAD CALISTOGA LLC10GILEAD SCIENCES INC7KRONOS BIO INC3POLNIASZEK RICHARD1YU RICHARD HUNG CHIU1
Top patents by PatentIndex Score
22 records- 0194US8865730B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2013·Granted Oct 21, 2014·25 cites·12 claims
- 0291US10059677B2Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereofGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 28, 2018·8 cites·14 claims
- 0390US10047060B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2017·Granted Aug 14, 2018·7 cites·2 claims
- 0489US9567337B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2014·Granted Feb 14, 2017·10 cites·44 claims
- 0588US10414737B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2018·Granted Sep 17, 2019·5 cites·24 claims
- 0688US9708327B2Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Jul 18, 2017·12 cites·47 claims
- 0788US9469643B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Oct 18, 2016·9 cites·6 claims
- 0886US9296779B2Processes and intermediates for preparing anti-HIV agentsGILEAD SCIENCES INC·Filed 2015·Granted Mar 29, 2016·3 cites·6 claims
- 0985US12152037B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Nov 26, 2024·1 cites·7 claims
- 1084US10730879B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 4, 2020·2 cites·4 claims
- 1183US10196419B2Processes and intermediates for preparing anti-HIV agentsGILEAD SCIENCES INC·Filed 2017·Granted Feb 5, 2019·1 cites·7 claims
- 1281US10442805B2Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2017·Granted Oct 15, 2019·3 cites·1 claims
- 1380US8987437B2Processes and intermediates for preparing anti-HIV AgentsYU RICHARD HUNG CHIU·Filed 2012·Granted Mar 24, 2015·6 cites·49 claims
- 1479US11339168B2Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitorsKRONOS BIO INC·Filed 2020·Granted May 24, 2022·1 cites·4 claims
- 1579US8853210B2Methods and intermediates for preparing pharmaceutical agentsGILEAD SCIENCES INC·Filed 2013·Granted Oct 7, 2014·4 cites·8 claims
- 1678US9783567B2Processes and intermediates for preparing anti-HIV agentsGILEAD SCIENCES INC·Filed 2016·Granted Oct 10, 2017·1 cites·5 claims
- 1777US10954199B2Process methods for phosphatidylinositol 3-kinase inhibitorsGILEAD CALISTOGA LLC·Filed 2019·Granted Mar 23, 2021·0 cites·20 claims
- 1877US8497396B2Methods and intermediates for preparing pharmaceutical agentsPOLNIASZEK RICHARD·Filed 2010·Granted Jul 30, 2013·7 cites·16 claims
- 1975US9115100B2Methods and intermediates for preparing pharmaceutical agentsGILEAD SCIENCES INC·Filed 2014·Granted Aug 25, 2015·2 cites·4 claims
- 2074US2025313566A1CRYSTALLINE FORMS OF 6-(6-AMINOPYRAZIN-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[l,2-a]PYRAZIN-8-AMINE AS SYK INHIBITORSKRONOS BIO INC·Filed 2024·Application pending·0 cites
- 2167US2019359644A1Processes and intermediates for preparing anti-hiv agentsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 2252US9428473B2Methods and intermediates for preparing pharmaceutical agentsGILEAD SCIENCES INC·Filed 2015·Granted Aug 30, 2016·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →